Best Medicines for Our Best Friends
KindredBio develops innovative medicines for cats, dogs, and horses.
Innovation
KindredBio is a leading veterinary biotech company in the world,
with extensive pipeline of drugs and recombinant protein therapeutics.
Our Mission
To bring the best science and medicine to our animal companions.
PURSUE PROVEN SCIENCE AND EFFECTIVE SOLUTIONS
We identify drugs and biologics that work in humans, and we develop veterinary versions for cats, dogs, and horses. By adapting the research and development from existing human products, we both increase the chance of success and decrease costs and timelines.
FOCUS ON EFFICIENCY
We have a world-class team, experienced in both human and veterinary therapeutic development and have selected best practices from both fields. Our methodical approach is resulting in groundbreaking veterinary drugs and biologics for an average of approximately $5 million to $8 million in only 3 to 5 years.
CREATE VALUE FOR ALL STAKEHOLDERS
We don’t compromise between the best veterinary treatments and return on investment. By efficiently adapting existing human treatments, we create value for everyone: cats, dogs, and horses, owners, veterinarians, and our employees and shareholders.
2019 Proxy Statement and 10-K now available
$7.60 
-0.08 (-1.04%)
-0.08 (-1.04%)
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
